One-third of primary care physicians do not support the use of medications for treating opioid use disorder

Credit: CC0 Public Domain

A survey of primary care physicians found that one-third did not perceive medications to treat opioid use disorder (OUD) to be more effective than nonmedication treatment or safe for long-term use, despite conclusive evidence to the contrary. Physicians also reported low interest in treating OUD and low support for policy proposals allowing office-based physicians to prescribe buprenorphine and methadone. These findings are reported in a brief research report published in Annals of Internal Medicine.

Researchers from Johns Hopkins Bloomberg School of Public Health and Johns Hopkins Center for Mental Health and Addiction Policy Research surveyed a random sample of 1,000 licensed physicians selected from a large U.S. database to find out their thoughts and attitudes about medications for OUD. Of 336 respondents, one fifth expressed interest in treating patients with OUD. Most of the physicians surveyed perceived buprenorphine as more effective than methadone or naltrexone, but very few reported prescribing these medications or obtaining a buprenorphine waiver. More than 81 percent of respondents supported increasing insurance coverage of government investment in OUD medication, but fewer than half supported allowing physicians to prescribe methadone for OUD in primary care settings or eliminating the buprenorphine waiver requirement.

According to the researchers, these findings suggest that policy changes alone are unlikely to lead to widespread availability of primary care-based medication. They urge efforts to increase ' acceptance of and willingness to prescribe medications for OUD.

More information: Study:

Journal information: Annals of Internal Medicine

Citation: One-third of primary care physicians do not support the use of medications for treating opioid use disorder (2020, April 21) retrieved 28 September 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Why are doctors underusing a drug to treat opioid addiction?


Feedback to editors